Anticancer effects of four ruthenium-cyclopentadienyl compounds in colorectal cancer cells: proteomic data

Colorectal cancer (CRC) is the second most deadly type of cancer worldwide. Ruthenium compounds have emerged as promising alternatives to classical chemotherapy in the treatment of CRC. The data available here refer the proteomic study performed with the four ruthenium-cyclopentadienyl compounds in colorectal cancer cells.